SCHEMBL20118162

SCHEMBL20118162

CC1=NN(c2ccc(F)cc2Cl)C(=O)[C@]12CC[C@H](N1C(=O)c3ccccc3C1=O)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
CASP6 P55212 1/20 0.40
TSHR P16473 1/20 0.39
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD11B1 P28845 2/20 0.34
DDB1 Q16531 1/20 0.34
CRBN Q96SW2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
HTT P42858 1/20 0.34
DRD2 P14416 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
IDO1 P14902 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20118395 0.88 KMT2A (0.39) KMT2AMEN1GAACASP6TSHR
SCHEMBL20118396 0.83 ADRA1D (0.36) KMT2AGAATSHRALDH1A1L3MBTL1
SCHEMBL20118108 0.82 PSEN1 (0.35) KMT2AMEN1GAACASP6ALDH1A1
SCHEMBL20118049 0.80 CASP6 (0.36) KMT2AMEN1GAACASP6ALDH1A1
SCHEMBL18208388 0.77 KMT2A (0.42) KMT2AMEN1GAACASP6TSHR
SCHEMBL18216046 0.77 KMT2A (0.42) KMT2AMEN1GAACASP6TSHR
SCHEMBL18208871 0.76 KMT2A (0.44) KMT2AMEN1GAACASP6TSHR
SCHEMBL18209085 0.75 KMT2A (0.42) KMT2AMEN1GAACASP6TSHR
SCHEMBL20118191 0.72 CRHR1 (0.43) KMT2AMEN1P2RX7
SCHEMBL20118132 0.70 LMNA (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018078009-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed